465 related articles for article (PubMed ID: 22125537)
1. Diabetes and alpha lipoic Acid.
Golbidi S; Badran M; Laher I
Front Pharmacol; 2011; 2():69. PubMed ID: 22125537
[TBL] [Abstract][Full Text] [Related]
2. Alpha-lipoic acid supplementation and diabetes.
Singh U; Jialal I
Nutr Rev; 2008 Nov; 66(11):646-57. PubMed ID: 19019027
[TBL] [Abstract][Full Text] [Related]
3. Alpha-lipoic acid as a pleiotropic compound with potential therapeutic use in diabetes and other chronic diseases.
Gomes MB; Negrato CA
Diabetol Metab Syndr; 2014; 6(1):80. PubMed ID: 25104975
[TBL] [Abstract][Full Text] [Related]
4. Lipoic acid as a potential therapy for chronic diseases associated with oxidative stress.
Smith AR; Shenvi SV; Widlansky M; Suh JH; Hagen TM
Curr Med Chem; 2004 May; 11(9):1135-46. PubMed ID: 15134511
[TBL] [Abstract][Full Text] [Related]
5. The Role of Alpha-lipoic Acid Supplementation in the Prevention of Diabetes Complications: A Comprehensive Review of Clinical Trials.
Jeffrey S; Samraj PI; Raj BS
Curr Diabetes Rev; 2021; 17(9):e011821190404. PubMed ID: 33461470
[TBL] [Abstract][Full Text] [Related]
6. alpha-Lipoic acid as a biological antioxidant.
Packer L; Witt EH; Tritschler HJ
Free Radic Biol Med; 1995 Aug; 19(2):227-50. PubMed ID: 7649494
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic Benefits of Alpha-Lipoic Acid Supplementation in Diabetes Mellitus: A Narrative Review.
Jeffrey S; Isaac Samraj P; Sundara Raj B
J Diet Suppl; 2022; 19(4):566-586. PubMed ID: 34939534
[TBL] [Abstract][Full Text] [Related]
8. Mitochondrial biogenesis: pharmacological approaches.
Valero T
Curr Pharm Des; 2014; 20(35):5507-9. PubMed ID: 24606795
[TBL] [Abstract][Full Text] [Related]
9. Antioxidants in the treatment of diabetes.
Golbidi S; Ebadi SA; Laher I
Curr Diabetes Rev; 2011 Mar; 7(2):106-25. PubMed ID: 21294707
[TBL] [Abstract][Full Text] [Related]
10. Alpha-lipoic acid: molecular mechanisms and therapeutic potential in diabetes.
Rochette L; Ghibu S; Muresan A; Vergely C
Can J Physiol Pharmacol; 2015 Dec; 93(12):1021-7. PubMed ID: 26406389
[TBL] [Abstract][Full Text] [Related]
11. Alpha-lipoic acid: A possible pharmacological agent for treating dry eye disease and retinopathy in diabetes.
Ajith TA
Clin Exp Pharmacol Physiol; 2020 Dec; 47(12):1883-1890. PubMed ID: 32621549
[TBL] [Abstract][Full Text] [Related]
12. Molecular and Therapeutic Insights of Alpha-Lipoic Acid as a Potential Molecule for Disease Prevention.
Tripathi AK; Ray AK; Mishra SK; Bishen SM; Mishra H; Khurana A
Rev Bras Farmacogn; 2023; 33(2):272-287. PubMed ID: 36778891
[TBL] [Abstract][Full Text] [Related]
13. Utilization of the insulin-signaling network in the metabolic actions of alpha-lipoic acid-reduction or oxidation?
Konrad D
Antioxid Redox Signal; 2005; 7(7-8):1032-9. PubMed ID: 15998258
[TBL] [Abstract][Full Text] [Related]
14. Effect of alpha-lipoic acid on the progression of endothelial cell damage and albuminuria in patients with diabetes mellitus: an exploratory study.
Morcos M; Borcea V; Isermann B; Gehrke S; Ehret T; Henkels M; Schiekofer S; Hofmann M; Amiral J; Tritschler H; Ziegler R; Wahl P; Nawroth PP
Diabetes Res Clin Pract; 2001 Jun; 52(3):175-83. PubMed ID: 11323087
[TBL] [Abstract][Full Text] [Related]
15. Advanced glycation end product-induced activation of NF-kappaB is suppressed by alpha-lipoic acid in cultured endothelial cells.
Bierhaus A; Chevion S; Chevion M; Hofmann M; Quehenberger P; Illmer T; Luther T; Berentshtein E; Tritschler H; Müller M; Wahl P; Ziegler R; Nawroth PP
Diabetes; 1997 Sep; 46(9):1481-90. PubMed ID: 9287050
[TBL] [Abstract][Full Text] [Related]
16. Early oxidative stress in the diabetic kidney: effect of DL-alpha-lipoic acid.
Obrosova IG; Fathallah L; Liu E; Nourooz-Zadeh J
Free Radic Biol Med; 2003 Jan; 34(2):186-95. PubMed ID: 12521600
[TBL] [Abstract][Full Text] [Related]
17. Alpha-lipoic Acid and diabetic neuropathy.
Vallianou N; Evangelopoulos A; Koutalas P
Rev Diabet Stud; 2009; 6(4):230-6. PubMed ID: 20043035
[TBL] [Abstract][Full Text] [Related]
18. Alpha-lipoic acid treatment ameliorates metabolic parameters, blood pressure, vascular reactivity and morphology of vessels already damaged by streptozotocin-diabetes.
Koçak G; Aktan F; Canbolat O; Ozoğul C; Elbeğ S; Yildizoglu-Ari N; Karasu C;
Diabetes Nutr Metab; 2000 Dec; 13(6):308-18. PubMed ID: 11232755
[TBL] [Abstract][Full Text] [Related]
19. [Lipoic acid: physiological role and prospects for clinical application].
Tutelyan VA; Makhova AA; Pogozheva AV; Shikh EV; Elizarova EV; Khotimchenko SA
Vopr Pitan; 2019; 88(4):6-11. PubMed ID: 31722135
[TBL] [Abstract][Full Text] [Related]
20. Lipoic acid in animal models and clinical use in diabetic retinopathy.
Nebbioso M; Pranno F; Pescosolido N
Expert Opin Pharmacother; 2013 Sep; 14(13):1829-38. PubMed ID: 23790257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
